FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., resulting in changes to the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia Heterozygous
• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

SUPPL AP for WELCHOL (COLESEVELAM HYDROCHLORIDE)